Topical means applied to the skin surface; systemic means reaching the skin through the whole body, usually by mouth or injection. The distinction governs how much of the body is affected, how closely something is supervised, and it is the fork most dermatology conversations turn on.
What does the distinction actually describe?
Route. Not strength, not seriousness, not how modern something is: simply how a treatment reaches the place it is meant to act on.
A topical treatment is applied to the skin surface and acts locally, which is what topical means and all it means. A systemic treatment is taken into the body, usually by mouth or by injection, and reaches the skin through the circulation along with everywhere else.
That single difference cascades into most of what follows. It determines how much of the body is exposed, what monitoring is appropriate, how quickly something can be stopped, and which conversations a prescriber needs to have with you first.
Why is a topical route not automatically the gentler one?
Because the skin is a barrier rather than a wall, and barriers are relative.
The outermost layer keeps most substances out, which is precisely why a topical treatment can be localised at all. But absorption still happens, and it varies enormously: thin skin absorbs more readily than thick skin, and skin whose barrier is already impaired by a condition absorbs more than intact skin does. The area covered matters, and so does whether anything occludes it.
This is why a prescriber considers the site as carefully as the preparation itself, and why moving a topical preparation from one part of the body to another is not the neutral act it appears to be.
The base, or vehicle, carries weight too. Ointments, creams, lotions and gels differ in how much of a substance reaches the skin and how long it stays, so the same active ingredient at the same concentration is not the same treatment in a different vehicle.
What does a systemic route change?
Its reach, and therefore its supervision.
A treatment acting through the whole body can address something that no topical approach can get to, which is the reason systemic treatment exists in dermatology at all. Widespread disease, conditions driven by processes the skin only displays, and disease that has not responded to localised approaches are the usual reasons it is considered.
The consequence is that assessment and monitoring extend beyond the skin. What that involves depends entirely on the specific treatment, and it is arranged by the prescriber. Anyone starting one should expect a longer conversation beforehand, covering other conditions, other medicines and circumstances that might bear on the choice.
Stopping is also less immediate than removing a cream from a bathroom shelf, which is one reason the decision to begin gets more discussion.
What sits between the two?
Several things, and the vocabulary is worth having.
Intralesional means delivered into a specific area rather than spread across a surface, concentrating an effect in one place while keeping it local. Phototherapy acts on an area of skin without being either applied or ingested, which is why it fits neither category.
Occlusion sits in a category of its own. Covering a treated area changes how much of a topical preparation is absorbed, sometimes substantially, which is why it is something a prescriber instructs rather than something to improvise.
Terms describing where a treatment goes turn up constantly in letters and in consultations, and knowing which side of the line a word sits on makes the rest of the sentence legible.
What is worth asking?
Ask which route is being proposed and why that one rather than the other. The reasoning is the useful part, and it usually reveals what the clinician thinks is driving the condition.
Enquire about the base, if a topical treatment is discussed, and whether it suits your life. A topical preparation unpleasant enough to be used sparingly performs worse than a duller one used properly, and prescribers would rather know that at the outset.
Ask what supervision a systemic treatment involves before agreeing to it, including how often you will be seen and what is being watched.
Ask what happens if a route is changed later. Dermatology frequently moves between the two, and knowing that in advance makes a change feel like a plan rather than a setback.
What this page does not do
It names no medicine, no concentration, no dose and no schedule, and it does not say which route suits any condition or any person. That decision rests with a prescriber who has examined your skin and knows the rest of your history.
Common questions
Is topical treatment always safer than systemic?
It is more localised, which is a real difference, but safer is too simple. Substances applied to the skin can be absorbed, particularly where skin is thin or the barrier is impaired, and systemic treatment is used precisely where a localised approach cannot reach far enough.
Why is a systemic treatment supervised more closely?
Because it reaches the whole body rather than one area, so its effects and its monitoring extend beyond the skin. Arrangements for that supervision are set by the prescriber and depend on the treatment, which is why they are discussed in detail before anything starts.
What does it mean if a treatment is described as intralesional?
It means delivered directly into a specific area rather than spread across the surface or taken by mouth. It sits between topical and systemic, concentrating an effect in one place, and it is one of several approaches that do not fit neatly on either side.
Does the base of a topical product matter?
Considerably. Whether something is an ointment, a cream, a lotion or a gel affects how much reaches the skin and how it stays there. Two products containing the same substance at the same concentration are not interchangeable if their bases differ.
Why does the site of application come up so often?
Because skin thickness varies enormously across the body, so the same topical preparation behaves differently on an eyelid and on a sole. Site is part of a prescribing decision rather than a detail, which is why a preparation is not simply moved from one area to another.
Sources
- Patient information on skin conditions and treatments — British Association of Dermatologists (United Kingdom) · accessed
- Guidance — National Institute for Health and Care Excellence (England) · accessed
Last updated . How this page was written.